The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

In this analysis, we explore the potential upside for Merck despite its short-term hurdles.

Shares of IndiaMart Intermesh jumped over 6% to Rs 2,650 on Tuesday after Nuvama Institutional Equities upgraded the stock to ‘Buy’ from ‘Reduce’ and raised the target price to Rs 3,800 ...

IndiaMART InterMESH settled at Rs 2,500 apiece on Tuesday. Nuvama's fresh target price suggests 52 per cent upside over this price.

MRK breaks above its 50-day average but near-term headwinds and weak China sales challenge the bullish case.

The illegal sale of scheduled drugs through a leading online portal has been curbed after stringent action was taken, the Tamil Nadu police said.

Merck & Co. won US approval for a shot that protects against RSV, the most common cause of hospitalization among infants.

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre ...

The Delhi HC has allowed IndiaMART to use the PUMA trademark in product descriptions, as it is a listing service, not an e-commerce site.

Inside IndiaMART’s evolving approach to smarter commerce IndiaMART CIO Nikhil Prabhakar shares how AI is powering smarter search, fraud detection, and platform security across India's leading B2B ...

With this, Livekeeping has become a wholly owned subsidiary of IndiaMART IndiaMART initially acquired a majority 51.09% stake in Livekeeping for INR 45.98 Cr in 2022 ...